3,4-Dihydroxyphenylacetaldehyde
3,4-Dihydroxyphenylacetaldehyde (DOPAL) is a catechol and an important intermediate in the metabolism of dopamine. It is a highly reactive compound that plays a significant role in the pathophysiology of neurodegenerative diseases, particularly Parkinson's disease.
Structure and Properties[edit | edit source]
3,4-Dihydroxyphenylacetaldehyde is a small organic molecule with the chemical formula C8H8O3. It contains a catechol moiety, which is a benzene ring with two hydroxyl groups at the 3 and 4 positions, and an aldehyde group attached to the side chain. This structure makes DOPAL highly reactive, especially towards nucleophiles, due to the presence of the aldehyde group.
Biosynthesis[edit | edit source]
DOPAL is formed during the catabolism of dopamine. The enzyme monoamine oxidase (MAO) catalyzes the oxidative deamination of dopamine to produce DOPAL. This reaction occurs in the mitochondria of neurons and other cells. The formation of DOPAL is a critical step in the metabolic pathway of dopamine, which eventually leads to the production of homovanillic acid (HVA), a major dopamine metabolite.
Role in Neurodegenerative Diseases[edit | edit source]
DOPAL is implicated in the pathogenesis of neurodegenerative diseases, particularly Parkinson's disease. Due to its reactive nature, DOPAL can form adducts with proteins, leading to protein aggregation and cellular toxicity. It is hypothesized that the accumulation of DOPAL and its interaction with neuronal proteins contribute to the neurodegeneration observed in Parkinson's disease.
Detoxification[edit | edit source]
The body has mechanisms to detoxify DOPAL and prevent its accumulation. The enzyme aldehyde dehydrogenase (ALDH) converts DOPAL into 3,4-dihydroxyphenylacetic acid (DOPAC), a less reactive and more stable compound. Additionally, glutathione can conjugate with DOPAL, further aiding in its detoxification.
Research and Clinical Implications[edit | edit source]
Understanding the role of DOPAL in dopamine metabolism and its contribution to neurodegenerative diseases is an active area of research. Therapeutic strategies aimed at reducing DOPAL levels or preventing its toxic interactions are being explored as potential treatments for Parkinson's disease and other related disorders.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
